Uterine receptivity and implantation: The regulation and action of insulin-like growth factor binding protein-1 (IGFBP-1), HOXA10 and forkhead transcription factor-1 (FOXO-1) in the baboon endometrium

In primates, the phase of the menstrual cycle wh en the uterus becomes receptive is initially dependent on estrogen and progesterone. Furt her morphological and biochemical changes are induced as a result of biochemical signals be tween the embryo and the maternal endometrium. Blastocyst implantation in the baboon usually occurs between 8 and 10 days post ovulation and is similar to that described for the rhesus macaque . In the baboon, when chorionic gonadotropin is infused in a manner that mimics blastocyst transit, this has physiological effects on the three major cell types in the uterine endometrium. The lu minal epithelium undergo es endoreplication and distinct epithelial plaques are evident. The glandular epithelium responds by inducing transcriptional and post-translational modifica tions in the major secretory pr oduct, glycodelin. The stromal fibroblasts initiate their differentiation process into a decidual phenotype and are characterized by the expression of actin filaments. Decidualization, is the major ch ange that occurs in the primate endometrium after conception. During this pr ocess the fibroblast-like stromal cells change morphologically into polygonal cells and express sp ecific decidual proteins. Studies in the baboon demonstrated that insulin-like growth factor binding protein-1 (I GFBP-1) gene expression is a conceptus-mediated response. Subsequent studies in vitro established that IGFBP-1 is transcriptionally regulated by FOXO1 and HO XA10 which together upregulate the IGFBP-1 promoter activity. A baboon en dometriosis model was utilized to determine if the changes observed during uterine receptivity in normal ly cycling animals were compromised. The data suggests that in animals with disease, markers of uterine re ceptivity are not appropriately expressed in the eutopic endometrium. It is possible that these differences influence the fertility of the animals with disease and the baboon could be used as a primate model to study the causes of infertility as a result of endometriosis.

The dialogue that occurs between the preimplantation embryo and the uterus is one of true elegance. Although the precise molecules and events involved remain unclear, it is well known that the initiation of pregnancy requires a precisely timed synchrony between endometrial develop- Published: 16 June 2004 Reproductive Biology and Endocrinology 2004, 2:34 doi:10.1186/1477-7827-2-34 Received: 01 March 2004 Accepted: 16 June 2004 This article is available from: http://www.rbej.com/content/2/1/34 © 2004 Kim and Fazleabas; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/34 Page 2 of 6 (page number not for citation purposes) ment and the implanting blastocyst. In primates, at the appropriate phase of the menstrual cycle, the uterus becomes "receptive" and enables the blastocyst to attach. This "receptive window" is initially dependent on estro- gen and progesterone. Further morphological and bio- chemical changes are induced within the uterus by signals from the developing embryo and following trophoblast invasion. Uterine receptivity and implantation in the baboon can be categorized into three distinct phases. Phase I is regu- lated by estrogen and progesterone and is evident between days 8 and 10 post-ovulation (PO) of the normal men- strual cycle. Morphologically it is characterized by the presence of columnar epithelium with microvilli and an increase in stromal cells proliferation [1]. At the biochem- ical level, there is a loss of estrogen receptor (ER α) and progesterone receptor (PR) in the luminal epithelium [2] together with a marked reduction of the polymorphic mucin, Muc-1 expression [3]. Coincident with the decrease in Muc-1 staining, there is an increase in smooth muscle myosin II (SMM II) expression in the luminal and glandular epithelium [4] and the appearance of pinopod- like structures on the surface epithelium, similar to those reported in the human [5]. The second phase of uterine receptivity is induced by blastocyst 'signals' superimposed on the estrogen/progesterone-primed receptive endometrium. This phase is associated with functional and morphological changes in the endometrium that are distinct from those observed at a comparable time of a nonpregnant cycle (i.e. phase I of uterine receptivity). Phase III of uterine receptivity is initiated following blast- ocyst attachment and implantation. A universal response is the significant increase in the permeability of the subep- ithelial capillaries surrounding the blastocyst [6,7]. In pri- mates the morphological changes associated with implantation have been extensively studied and elegantly reviewed by Enders [8]. In general, together with glandu- lar hypertrophy, stromal cell decidualization is initiated and is accompanied by increased extracellular matrix (ECM) accumulation. In this review, a brief summary of the studies in the baboon that demonstrate the modulation of the uterus by embryonic signals (Phase II) is given. The molecular regu- lation of stromal cell differentiation (Phase III) will be the focus of this review and the aberration of uterine receptiv- ity in baboons with endometriosis will be discussed. Influence of embryonic signals on uterine receptivity – phase II Several lines of evidence demonstrate that embryo- derived factors directly or indirectly influence endome- trial receptivity and implantation in primates. Studies in the rhesus monkey indicate that endometrial physiology during the midluteal phase in the presence of the concep- tus is discernibly different from that in the nonfecund midluteal phase [9]. An early maternal response to preg- nancy in the luminal epithelium of primates is the forma- tion of the epithelial plaque [10]. This response is characterized by hypertrophy of the surface epithelium and cells in the neck glands that round up and form acinar clusters [11,12]. In the baboon, chorionic gonadotropin (CG), when infused in a manner that mimics blastocyst transit, has physiological effects on the three major cell types in the uterine endometrium (i.e. luminal and glan- dular epithelium and stromal fibroblasts [13]). The effects of CG on glandular transformation and stromal cell differ- entiation are direct, and occur independent of the ovary [13]. The glandular response to CG infusion is character- ized by a marked increase in transcriptional and post- translational modulation of glycodelin [13]. Synthesis of glycodelin by the glandular epithelium parallels the rise and later decline of CG in the peripheral circulation [14]. The primary effect of CG on stromal fibroblasts is the induction of α-smooth muscle actin ( αSMA; 13, 15). It has been hypothesized that the induction of αSMA in stromal fibroblasts occurs as a consequence of the binding of integrins on the stromal cell membranes (that are also induced in response to CG) to secreted ECM proteins [16]. The interaction between integrins and the ECM induces changes in the actin cytoskeleton that are thought to be critical for signal transduction [17,18]. Decidualization – phase III One of the fundamental requirements for the successful establishment and maintenance of pregnancy in the pri- mate is the decidualization of the endometrium. Decidu- alization is defined as the differentiation of the fibroblast- like mesenchymal cells in the endometrium to a decidual cell which is morphologically and biochemically distinct [19]. The decidualized cell biochemically expresses new proteins such as prolactin and insulin-like growth factor binding protein-1 (IGFBP-1; 1). In the human, regardless of whether implantation occurs, stromal edema is observed on day 23 of the menstrual cycle and is followed 3 to 4 days later by a predecidual reaction which begins around the spiral arteries and spreads through the upper two-thirds of the endometrium [20]. If implantation occurs, the reaction is intensified and becomes the decidua of pregnancy. In contrast, the baboon does not undergo a predecidual reaction during the menstrual cycle [12,21]. However, following implan- tation, the stromal fibroblasts undergo extensive modifi- cation to form the decidua in the baboon (11,12, 22). Turner [23] and Bryce and Teacher [24] first suggested that decidualization is regulated by the trophoblast. In vivo data clearly demonstrate that decidualization in the baboon, based on IGF-I receptor, IGFBP-1 and prolactin Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/34 Page 3 of 6 (page number not for citation purposes) expression, is a conceptus-induced phenomenon, first evi- dent at the implantation site between days 18 and 25 of pregnancy [25,26]. Treatment of endometrial stromal cells in cell culture with estrogen and progesterone, which can decidualize human stromal cells, is insufficient to fully decidualize stromal cells isolated from the baboon endometrium. An additional factor, i.e. dibutyryladenos- ine 3':5' cyclic monophosphate (dbcAMP) is required, suggesting that a conceptus-mediated factor involving cAMP-mediated pathways is important in the baboon [27]. Although there are many studies that have defined the morphological and biochemical end points of a decidual cell [12,28], the sequence of cellular and molecular events associated with the transformation of a stromal fibroblast to a secretory decidual cell has yet to be elucidated. IGFBP- 1 is not only a marker for decidualization but also a para- crine/autocrine factor which is intimately involved in the sequence of events leading from implantation to normal fetal outcome. By studying the factors which regulate IGFBP-1 gene expression, a general sense of the types of changes that occur during the process of decidualization can be obtained. IGFBP-1 gene regulation Many studies have demonstrated the regulation of the IGFBP-1 gene in both the liver and the endometrium. Multiple factors contribute to the regulation of IGFBP-1 gene expression, including insulin, glucocorticoids, pro- gesterone, cytokines and hypoxia [29-32]. In the decidual- ized human endometrium, progesterone induces IGFBP-1 synthesis perhaps via a glucocorticoid response element [33]. Further modulation of its expression in vitro is medi- ated by cAMP [34]. Many of the important cis-regulatory elements are located within 500 bp of the transcription start site. [35]. The hepatocyte nuclear factor 1 (HNF1) binding region, insulin response element (IRE), gluoco- corticoid response element (GRE) and TATA element are highly conserved among the human, rat and mouse IGFBP-1 promoters, suggesting a crucial, evolutionarily conserved role for these gene promoter regions in its reg- ulation. In the recent years, there has been great interest in the regulation of IGFBP-1 by FOXO1, a member of the FOXO sub-family of forkhead/winged-helix family of transcription factors in liver-derived cells [36-39]. The DNA-binding domain of FOXO1 is comprised of three tightly packed alpha helical domains and a C-terminal basic region [40]. It is the third helix (H3) that establishes DNA base contacts within the major groove of its recogni- tion sequence. The IGFBP-1 promoter contains an FOXO1 binding site (GCAAAACAA) in the IRE of the human IGFBP-1 promoter. FOXO1 is expressed in the baboon endometrium and is upregulated during the luteal phase of the menstrual cycle which intensifies during pregnancy [35]. Furthermore, FOXO1 can upregulate the IGFBP-1 promoter in endome- trial stromal cells [35]. Studies have shown FOXO1 to physically associate with additional nuclear transcription factors and cause repression or transactivation of genes. FOXO1 can interact with the estrogen receptor, retinoic acid receptor, and thyroid hormone receptor causing either repressive or activating effects on nuclear receptor mediated genes [41,42]. FOXO1 can also associate with and function cooperatively with CCAAT/enhancer-bind- ing protein (C/EBP) beta to cause a significant upregula- tion of the decidual prolactin promoter in response to cAMP agonists [43]. FOXO1 can physically associate with HOXA10, another nuclear transcription factor which then acts cooperatively to increase the IGFBP-1 promoter activ- ity [35]. HOXA10 is one member of the homeobox (HOX) gene family. Homeobox genes are involved in the genetic con- trol of development, in particular in the specification of the body plan, pattern formation, the determination of cell fate, and several other basic developmental processes (reviewed in 44). Proteins in the homeobox gene family contain a unique homeodomain that is a 61 amino acid residue polypeptide which represents the DNA-binding domain of the proteins. HOX proteins can regulate genes in adult tissues. Hoxa5 [45] and HOXA10 [46] stimulate the p53 promoter in breast cancer cells and promote the expression of the pro- gesterone receptor [47]. Other targets of HOXA10 regula- tion include beta 3 integrin [48] and empty spiracles homolog 2(EMX2) [49]. In the developing reproductive tract, four genes of the HOXA cluster (HOXA9, HOXA10, HOXA11, and HOXA13) are expressed [50]. HOXA10 is expressed in the developing uterus, specifically in the endometrial glands and stroma of the endometrium where its expression is dependent on the stage of the men- strual cycle, dramatically increasing at the time of implan- tation [50-52]. HOXA10 deficient mice exhibit uterine factor infertility due to implantation defects. Specifically, decidualization of the endometrium is severely compro- mised during blastocyst implantation [53]. The role of HOX genes on IGFBP-1 regulation has been demonstrated for the first time using transgenic mice over-expressing HOXA5. These mice exhibit a 12-fold increase of IGFBP-1 expression in the liver and undergo growth arrest during weeks two and three of postnatal development, resulting in proportionate dwarfism [54]. HOXA10 has a modest effect on IGFBP-1 promoter activity, but when FOXO1 is present, promoter activity is upregulated in a cooperative manner [35]. For this to occur, binding of FOXO1 to the IRE is required. Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/34 Page 4 of 6 (page number not for citation purposes) Studies have suggested that HOX family members interact with cofactors such as PBX, the mammalian homolog of Drosophila extradenticle [55-57]. It is believed that interac- tions with PBX cofactors may contribute to the regulatory control and refinement of HOX protein function. Given that there is a high proportion of presumptive HOX bind- ing sites on any given promoter and the affinity of HOX proteins for nonspecific sites is relatively strong, it is not unreasonable to assume a need for cofactors for site-spe- cific recognition. It is possible that there are multiple potential HOXA10 binding sites on the IGFBP-1 pro- moter. Whether these binding sites are functional may depend on the availability of FOXO1 to interact with HOXA10 and assist in its recruitment to the IGFBP-1 pro- moter. It is possible that HOXA10 stabilizes FOXO1 DNA binding and in turn modulates specificity of HOX DNA binding. The cooperative action of FOXO1 and HOXA10 is highly intriguing with great potential implications. Not only are FOXO1 and HOX transcription factors expressed in numerous tissues and cell types, these two transcription factors have independently been shown to be critical reg- ulators of genes. The possibility that FOXO1 and HOX proteins, by associating with one another can regulate genes more powerfully and specifically than by them- selves, is extremely provocative. The repertoire of gene expression during conceptus- induced decidualization is very different from a non-preg- nant endometrium. When critical genes are aberrantly expressed during the decidualization process or even dur- ing the window of implantation, this could result in the failure of the blastocyst to implant or inadequate implan- tation. Studies have demonstrated that the eutopic endometrium of women with endometriosis expresses an aberrant pattern of genes and several markers of uterine receptivity are abnormally or not expressed [58]. Uterine receptivity in endometriosis Women and baboons with endometriosis have a lowered fecundity [59,60]. Endometriosis, which is characterized by the presence of a functional endometrium outside of the uterine cavity, is a condition that affects five million American women. The etiology of endometriosis is unclear; however, the most widely accepted hypothesis for its development is retrograde menstruation, where frag- ments of menstrual endometrium are refluxed through the fallopian tubes into the peritoneal cavity [61]. The baboon has been used as a model to understand this dis- ease. Intraperitoneal autotransplantation of menstrual endometrium in the baboon results in experimental endometriosis, supporting Sampson's theory of retro- grade menstruation. This method of induction resulted in red raised and reddish-blue implants to scared lesions with powder-black appearance that were macroscopically similar to those seen in women with spontaneous endometriosis [62]. There is also evidence that the baboon can spontaneously develop endometriosis: how- ever, it is unclear whether this is truly a spontaneous con- dition or whether it is induced by repetitive surgical manipulation [63]. Glycodelin, αSMA, and αvβ3, which have been previously characterized as markers of uterine receptivity, are absent from eutopic endometrium during the window of implantation in baboons and humans with endometrio- sis [59,64]. The lack of induction of glycodelin and αSMA is seen at early stages of endometriosis in the baboon. An understanding of the mechanisms by which the expres- sion of these genes is controlled may elucidate the reasons for implantation failure in women with endometriosis. In recent years, studies have shown that the gene expres- sion profile in the endometrium of women with endome- triosis is aberrant [58,65-68]. HOXA10 downregulated in the endometrium of women with endometriosis [69]. Since transcription factors activate or repress genes, it is possible that the aberration lies in the expression or func- tion of transcription factors. We collected preliminary data showing that in stromal cells isolated from the endometrium of baboons with endometriosis, FOXO1 and HOXA10 had a minimal effect on the IGFBP-1 pro- moter. Interestingly, the cooperative effect of FOXO1 and HOXA10 was also repressed. These cells were isolated from baboons with endometriosis that have been consid- ered to be subfertile. These intriguing data suggest that the cells from animals with endometriosis are different from those of normal baboons. One can speculate that if the cooperative action of FOXO1 and HOXA10 does not occur in these cells, the upregulation of IGFBP-1 to neces- sary levels may not occur, which may somehow be associ- ated with the infertile status of the animal. Furthermore, if the cooperative action of FOXO1 and HOXA10 does not occur, other relevant gene expression may also be inade- quate. To date, it is unclear why certain genes are down- regulated or abnormally expressed in endometriosis. Determining the mechanisms responsible for the dysreg- ulation of genes will give us a better understanding of the potential causes of infertility associated with endometrio- sis.

The use of the baboon as an animal model to study uter- ine receptivity and implantation has been invaluable. Much information on the morphological, biochemical and molecular events that occur during early pregnancy has been generated. There is direct evidence of endome- trial modulation by local infusion of CG demonstrating that embryonic signals directly act on the endometrium in Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/34 Page 5 of 6 (page number not for citation purposes) primates. The implanted embryo promotes decidualiza- tion of the endometrium which is essential for the estab- lishment of pregnancy and potential transcription factors within the endometrium that may play a role in this proc- ess have been identified. With the use of these experimen- tal paradigms, it has been shown that endometriosis affects uterine receptivity in the baboon. Elucidating the cellular and molecular events associated with uterine receptivity and implantation will have significant implica- tions in understanding the fundamental causes of implan- tation failure and subsequent infertility.

These studies were supported by NIH Grants HD 36759 & HD 40093.

1. Hild-Petito S, Donnelly KM, Miller JB, Verhage HG, Fazleabas AT: A baboon (Papio anubis) simulated-pregnant model: cell spe- cific expression of insulin-like growth factor binding protein- 1 (IGFBP-1), type I IGF receptor (IGF-I R) and retinol bind- ing protein (RBP) in the uterus. Endocrine 1995, 3:639-651. 2. Hild-Petito S, Verhage HG, Fazleabas AT: Immunocytochemical localization of estrogen and progestin receptors in the baboon (Papio anubis) uterus during implantation and early pregnancy. Endocrinology 1992, 130:2343-2353. 3. Hild-Petito S, Fazleabas AT, Julian JA, Carson DD: Mucin (Muc-1) expression is differentially regu lated in uterin e luminal and glandular epithelia of the baboon ( Papio anubis). Biol Reprod 1996, 54:939-947. 4. Christensen S, Verhage HG, Nowa k G, deLanerolle P, Flemming S, Bell SC, Fazleabas AT, Hild-Petito S: Smooth muscle myosin II and α-muscle actin expression in the baboon ( Papio anubis) uterus is associated with glandular secretory activity and stromal cell transformation. Biol Reprod 1995, 53:598-608. 5. Martel D, Frydman R, Glissant M, Maggioni C, Roche D: Scanning electron microscopy of postovulatory human endometrium in spontaneous cycles and cycles stimulated by hormone treatment. J Endocrinol 1997, 114:319-324. 6. Psychoyos A: Endocrine control of egg implantation. In Hand- book of Physiology Female Reproduc tive System Endocrinology Section 7 Volume 2. Issue Part 2 Edited by: Green RO. Washington, DC: Amer- ican Physiological Society; 1973:187-215. 7. Psychoyos A: The implantation window: basic and clinical aspects. In Perspectives in Assisted Reproduction, Ares Serono Symposia (Rome) 1993, 4:57-62. 8. Enders AC: Overview of the morphology of implantation in primates. In In Vitro Fertilization and Embryo Transfer in Primates Edited by: Wolf RL, Stouffer RL , Brenner RM. New York: Springer; 1993:145-157. 9. Ghosh D, Sengupta J: Recent developments in endocrinology and paracrinology of blastocyst implantation in the primate. Hum Reprod Update 1998, 4:153-168. 10. Enders AC, Lantz KC, Peterson PE, Hendrickx AG: From blasto- cyst to placenta: the morpholo gy of implantation in the baboon. Hum Reprod Update 1997, 3:561-573. 11. Tarara R, Enders AC, Hedrickx AG: Early implantation and embryonic development of the baboon: stages 5–7. Anat Embryol 1987, 176:267-275. 12. Enders AC: Structural responses of the primate endometrium to implantation. Placenta 1991, 12:309-325. 13. Fazleabas AT, Donnelly KM, Srin ivasan S, Fortman JD, Miller JB: Mod- ulation of the baboon ( Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity. Proc Natl Acad Sci USA 1999, 96:2543-2548. 14. Hausermann HM, Donnelly KM, Be ll SC, Verhage HG, Fazleabas AT: Regulation of the glycosylated β-lactoglobulin homologue, glycodelin [placental protein 14 (PP 14)] in the baboon uterus. J Clin Endocrinol Metab 1998, 83:1226-1233. 15. Fazleabas AT, Hild-Petito S, Verhage HG: The primate endometrium: morphological and secretory changes during early pregnancy. Semin Reprod Endocrinol 1995, 13:120-132. 16. Fazleabas AT, Bell SC, Fleming S, Sun J, Lessey BA: Distribution of integrins and the extracellular matrix proteins in the baboon endometrium during the menstrual cycle and early preg- nancy. Biol Reprod 1997, 56:348-356. 17. Clark EA, Brugge JS: Integrins and signal transduction path- ways: the road taken. Science 1995, 268:233-239. 18. Dedhar S: Integrin-mediated signal transduction in oncogen- ensis: an overview. Cancer Metastasis Rev 1995, 14:165-172. 19. Tabanelli S, Tang B, Gurpide E: In vitro decidualization of human endometrial cells. J Steroid Biochem Molec Biol 1992, 42:337-344. 20. Wynn RM: Ultrastructural deve lopment of the human decidua. Am J Obstet Gynecol 1974, 118:652-670. 21. Ramsey EM, Houston ML, Harris JWS: Interactions of the tro- phoblast and maternal tissues in three closely related pri- mates. Am J Obstet Gynecol 1976, 124:647-652. 22. Enders AC, Schlafke S: Implantation in non-human primates and human. In: Comparative Primate Biology: Reproduction and Devel- opment Volume 3. Edited by: Alan R. New York: Liss; 1986:291-310. 23. Turner W: Lectures on the comparative anatomy of the pla- centa. In: First series, A and C Block Edinburgh; 1876. 24. Bryce TH, Teacher JH: Contribution to the study of early devel- opment and embedding of the human ovum. Glasgow: Macle- Hose 1908. 25. Tarantino S, Verhage HG, Fazleabas AT: Regulation of insulin-like growth factor binding proteins in the baboon (Papio anubis) uterus during early pregnancy. Endocrinology 1992, 130:2354-2362. 26. Hild-Petito S, Verhage HG, Fazleabas AT: Characterization, local- ization and regulation of re ceptors for insulin-like growth factor (IGF)-I in the baboon uterus during the cycle and early pregnancy. Biol Reprod 1994, 50:791-801. 27. Kim JJ, Jaffe RC, Fazleabas AT: Comparative studies on the in vitro decidualization process in baboons and humans. Biol Reprod 1998, 59:160-168. 28. Glasser S: Biochemical and structural changes in uterine endometrial cell types following natural or artificial deciduo- genic stimuli – A review. In: Trophoblast Invasion and Endometrial Receptivity, Trophoblast Res 1990, 4:377-416. 29. Lee PDK, Giudice LC, Conover CA, Powell DR: Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997, 216:319-357. 30. Tazuke SI, Mazure N, Sugawara J, Carland G, Faessen GH, Suen LF, Irwin JC, Powell DR, Giaccia AJ, Giudice LC: Hypoxia stimulates insulin-like growth factor bi nding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible mode l for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA 1998, 95:10188-10193. 31. Gao J, Tseng L: Progesterone receptor (PR) inhibits expres- sion of insulin-like growth fa ctor-binding protein-1 (IGFBP- 1) in human endometrial cell line HEC-1B: Characterization of the inhibitory effect of PR on the distal promoter region of the IGFBP-1 gene. Mol Endocrinol 1997, 11:973-979. 32. Suwanichkul A, Allander SV, Morris SL, Powell DR: Glucocorticoids and insulin regulate expression of the human gene for insu- lin-like growth factor-binding protein-1 through proximal promoter elements. J Biol Chem 1994, 269:30835-30841. 33. Gao JG, Mazella J, Tseng L: Activation of the human IGFBP-1 gene promoter by progestin and relaxin in primary culture of human endometrial stromal cells. Mol Cell Endocrinol 1994, 104:39-46. 34. Tang B, Guller S, Gurpide E: Cyclic adenosine 3',5'-monophos- phate induces prolactin express ion in stromal cells isolated from human proliferative endometrium. Endocrinology 1993, 133:2197-2203. 35. Kim JJ, Taylor HS, Akbas GE, Fouche r I, Trembleau A, Jaffe RC, Fazlea- bas AT, Unterman TG: Regulation of insulin-like growth factor binding protein-1 promoter activity by FKHR and HOXA10 in primate endometrial cells. Biol Reprod 2003, 68:24-30. 36. Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T: Phosphoryla- tion of serine 256 protein kina se B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 1999, 274:17184-17192. 37. Tomizawa M, Kumar A, Perrot V, Nakae J, Accili D, Rechler MM, Kumar A: Insulin inhibits the activati on of transcription by a Publish with BioMed Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/34 Page 6 of 6 (page number not for citation purposes) C-terminal fragment of the fo rkhead transcription factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription. J Biol Chem 2000, 275:7289-7295. 38. Cichy SB, Uddin S, Daniilkovich A, Guo S, Klippel A, Unterman TG: Protein kinase B/Akt mediates ef fects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence. J Biol Chem 1998, 273:6482-6487. 39. Durham SK, Suwanichkul A, Sche imann AO, Yee D, Jackson JG, Barr FG, Powell DR: FKHR binds to the insulin response element in the insulin-like growth factor binding prote in-1 promoter. Endocrinology 1999, 140:3140-3146. 40. Clark KL, Halay ED, Lai E, Burley SK: Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993, 364:412-420. 41. Schuur ER, Loktev AV, Sharma M, Sun Z, Roth RA, Weigel RJ: Lig- and-dependent interaction of estrogen receptor-a with members of the forkhead tr anscription factor family. J Biol Chem 2001, 276:33554-33560. 42. Zhao HH, Herrera RE, Coronado -Heinsohn E, Yang MC, Ludes-Mey- ers JH, Seybold-Tilson KJ, Nawaz Z, Yee D, Barr FG, Dia SG, Brown PH, Fuqua SAW, Osborne CK: Forkhead homologue in rhab- domyosarcoma functions as a bifunctional nuclear receptor- interacting protein with both coactivator and corepressor functions. J Biol Chem 2001, 276:27907-27912. 43. Christian M, Zhang X, Schneide r-Merck T, Unterman TG, Gellersen B, White JO, Brosens JJ: Cyclic AMP-induced forkhead tran- scription factor, FKHR, cooperates with CCAAT/enhancer- binding protein beta in differentiating human endometrial stromal cells. J Biol Chem 2002, 277:20825-20832. 44. Gehring WJ: Homeoboxes in the study of development. Science 1987, 236:1245-1252. 45. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S: Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000, 405:974-978. 46. Chu MC, Taylor HS: HOXA10 is expressed in human breast cancer cell lines and regulates p53 expression. J SGI 2001, Supp 8:131A. Abstract #285 47. Raman V, Tamori A, Vali M, Zeller K, Korz D, Sukumar S: Hoxa5 regulates expression of the progesterone receptor. J Biol Chem 2000, 275:26551-26555. 48. Daftary GS, Troy PJ, Bagot CN, Young SL, Taylor HS: Direct regu- lation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells. Mol Endocrinol 2002, 16:571-579. 49. Troy PJ, Daftary GS, Bagot CN, Taylor HS: Transcriptional repres- sion of peri-implantation EM X2 expression in mammalian reproduction by HOXA10. Mol Cell Biol 2003, 23:1-13. 50. Taylor HS, Vanden Heuvel GB, Igarashi P: A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 1997, 57:1338-1345. 51. Gui Y, Zhang J, Yuan L, Lessey BA: Regulation of HOXA-10 and its expression in normal and abnormal endometrium. Mol Hum Reprod 1999, 5:866-873. 52. Taylor HS, Arici A, Olive D, Igarashi P: HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 1998, 101:1379-1384. 53. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL: Mecha- nisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of matern al Hoxa-10 expression. Develop- ment 1996, 122:2687-2696. 54. Foucher I, Volovitch M, Frain M, Kim JJ, Souberbielle JC, Gan L, Unter- man TG, Prochiantz A, Trembleau A: Hoxa5 over-expression cor- relates with IGFBP1 up-regulation and postnatal dwarfism: evidence for an interaction between Hoxa5 and Forkhead box transcription factors. Development 2002, 129:4065-4074. 55. Ekker SC, von Kessler DP, Beachy PA: Differential DNA sequence recognition is a determinant of specificity in homeotic gene action. EMBO J 1992, 11:4059-4072. 56. Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, Clearly ML: Pbx proteins display hexapeptide-dependent coopera- tive DNA binding with a subset of Hox proteins. Genes Dev 1995, 9:663-674. 57. Knoepfler PS, Kamps MP: The pentapeptide motif of Hox pro- teins is required for cooper ative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1. Mol Cell Biol 1995, 15:5811-5819. 58. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC: Expression profilin g of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003, 144:2870-2881. 59. Lessey BA, Castelbaum AJ, Sawin SJ, Buck CA, Schinnar R, Bilker W, Strom BL: Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994, 79:643-649. 60. D'Hooghe TM: Clinical relevance of the baboon as a model for the study of endometriosis. Fertil Steril 1997, 68:613-625. 61. Sampson JA: Peritoneal endometriosis is due to menstrual dis- semination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927, 14:422-469. 62. Fazleabas AT, Brudney A, Gurates B, Chai D, Bulun S: A modified model for endometriosis. Ann NY Acad Sci 2002, 955:308-317. 63. D'Hooghe TM, Bambra CS, Raeymaekers BM, Koninckx PR: Increased prevalence and recurrence of retrograde men- struation in baboons with spontaneous endometriosis. Hum Reprod 1996, 11:2022-2025. 64. Fazleabas AT, Brudney A, Chai D, Langoi D, Bulun SE: Steroid receptor and aromatase expre ssion in baboon endometri- otic lesions. Fertil Steril 2003, 80(Suppl 2):820-827. 65. Williams CD, Goggess JF, LaMarque LR, Meyer WR, Murray MJ, Fritz MA, Lessey BA: A prospective, randomized study of endome- trial telomerase during the menstrual cycle. J Clin Endocrinol Metab 2001, 86:3912-3917. 66. Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E: Gly- codelin: a major lipoc alin protein of th e reproductive axis with diverse actions in cell re cognition and differentiation. Endocr Rev 2002, 23:401-430. 67. Eyster K, Boles A, Br annian J, Hansen K: DNA microarray analysis of gene expression markers of endometriosis. Fertil Steril 2002, 77:38-42. 68. Gogusev J, Bouquet de Joliniere J, Telvi L, Doussau M, du Manoir S, Stojkoski A, Levardon M: Genetic abnormalities detected by comparative genomic hybridization in a human endometri- osis-derived cell line. Mol Hum Reprod 2000, 6:821-827. 69. Taylor HS, Bagot C, Kardana A, Olive D, Arici A: HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 1999, 14:1328-1331.